N-Benzylaniline

N-Benzylaniline

SCHEMBL28648928

O=C(O)C=Cc1ccccc1.c1ccc(CNc2ccccc2)cc1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 10/20 0.70
MEF2D Q14814 9/20 0.70
FFAR1 O14842 3/20 0.64
HDAC1 Q13547 3/20 0.61
HDAC3 O15379 2/20 0.61
HDAC2 Q92769 2/20 0.61
HDAC8 Q9BY41 2/20 0.61
TNKS O95271 1/20 0.61
HCAR2 Q8TDS4 1/20 0.61
HDAC7 Q8WUI4 1/20 0.61
HDAC10 Q969S8 1/20 0.61
HDAC11 Q96DB2 1/20 0.61
TNKS2 Q9H2K2 1/20 0.61
HDAC6 Q9UBN7 1/20 0.61
HDAC9 Q9UKV0 1/20 0.61
HDAC5 Q9UQL6 1/20 0.61
MMP1 P03956 3/20 0.59
MMP2 P08253 3/20 0.59
MMP9 P14780 3/20 0.59
EP300 Q09472 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21221175 0.91 HDAC4 (0.80) HDAC4MEF2DFFAR1EP300
SCHEMBL21221174 0.91 HDAC4 (0.80) HDAC4MEF2DFFAR1EP300
SCHEMBL24046635 0.89 HDAC4 (0.69) HDAC4MEF2DFFAR1EP300
SCHEMBL21232320 0.83 HDAC4 (1.00) HDAC4MEF2DEP300
SCHEMBL10456019 0.81 HDAC4 (0.75) HDAC4MEF2DFFAR1HDAC1HDAC3
Cinnamic Acid SCHEMBL890441 0.79 HCAR2 (0.76) HDAC4FFAR1HDAC1HDAC3HDAC2
SCHEMBL1068653 0.79 FFAR1 (0.55) HDAC4MEF2DFFAR1HDAC1MMP1
Cinnamic Acid SCHEMBL3406486 0.78 HCAR2 (1.00) HDAC4FFAR1HDAC1HDAC3HDAC2
Cinnamic Acid SCHEMBL50466 0.78 HCAR2 (1.00) HDAC4FFAR1HDAC1HDAC3HDAC2
Cinnamic Acid SCHEMBL653827 0.78 HCAR2 (1.00) HDAC4FFAR1HDAC1HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108026028-B Treatment of diabetes and metabolic syndrome with novel dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptors 威斯康星州医药大学股份有限公司 2021-11-09 CN disclosed